Ampliació del període de control de tractament anticoagulant oral (TAO) [cartell]
Abstract
The control period of stable patients is allowed to be extended to avoid exposure to anticoagulant patients
Keywords
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Oral anticoagulant treatment; Dicumarinics; International Normalized RatioBibliographic citation
Ampliació del període de control de tractament anticoagulant oral (TAO) [cartell]. Barcelona: Institut Català de la Salut; 2020.
Audience
Professionals
This item appears in following collections
The following license files are associated with this item:




